Merck (MRK) Non Operating Income (2009 - 2026)

Merck has disclosed Non Operating Income across 18 years of filings, most recently posting -$138.0 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 494.29% year-over-year to -$138.0 million; the TTM figure through Mar 2026 stood at -$325.0 million (down 1260.71% YoY), while the FY2025 annual figure was -$151.0 million, down 729.17% from the prior year.
• Non Operating Income advanced to -$138.0 million in Q1 2026, from -$432.0 million in the prior quarter.
• Over the last five years, Non Operating Income for MRK reached as high as $238.0 million in Q3 2025 and fell as low as -$708.0 million in Q1 2022.
• The 5-year median for Non Operating Income is -$89.0 million (2023), against an average of -$131.1 million.
• Annual changes were most pronounced in 2022 — Non Operating Income tumbled 525.24% — and 2024, when it jumped 228.57%.
• A 5-year view of Non Operating Income shows it stood at $75.0 million in 2022, then tumbled by 204.0% to -$78.0 million in 2023, then plunged by 62.82% to -$127.0 million in 2024, then plunged by 240.16% to -$432.0 million in 2025, then soared by 68.06% to -$138.0 million in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered -$138.0 million, -$432.0 million, and $238.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.